| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 2-Jan-09 | | Total Revenue | 54,976 | 27,403 | 25,302 | 29,572 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 54,976 | 27,403 | 25,302 | 29,572 | | | Operating Expenses | | Research Development | 60,187 | 55,036 | 55,344 | 56,878 | | Selling General and Administrative | 11,607 | 10,378 | 6,732 | 9,106 | | Non Recurring |
-
|
-
|
-
| 2,890 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (16,818) | (38,011) | (36,774) | (39,302) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 355 | (7,659) | 554 | 933 | | Earnings Before Interest And Taxes | (16,463) | (45,670) | (36,220) | (38,369) | | Interest Expense | 2,122 | 2,118 | 2,116 | 2,376 | | Income Before Tax | (18,585) | (47,788) | (38,336) | (40,745) | | Income Tax Expense | 6,860 | (846) |
-
|
-
| | Minority Interest | 4,337 |
-
|
-
| 2,796 | | | | Net Income From Continuing Ops | (21,108) | (46,942) | (38,336) | (37,949) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (21,108) | (46,942) | (38,336) | (37,949) | | Preferred Stock And Other Adjustments | (4,337) | 2,181 | 2,156 |
-
| | | Net Income Applicable To Common Shares | ($25,445) | ($44,761) | ($36,180) | ($37,949) |
|
1.45% Nasdaq 
Income Statement
